- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 1, 2026 | 10.11M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 9.75M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 9.28M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 8.75M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 8.74M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $12K |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $0 |
| Capex | Q3 2026 · Mar 31, 2026 | $876K |
| Capex restated | Q3 2026 · Mar 31, 2025 | $408K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $2.32M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $1.04M |
| Short Term Investments | Q3 2026 · Mar 31, 2026 | $2.56M |
| Short Term Investments | Q3 2026 · Jun 30, 2025 | $5.82M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $12.97M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $10.89M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $34.33M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $34.03M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $9.86M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $6.28M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $12.25M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $7.08M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $33.27M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $31.58M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $44.72M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $41.07M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $39.96M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.02 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$0.06 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.02 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$0.06 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$0.03 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $2.27M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $6.64M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $2.07M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $6M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $99K |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $299K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $90K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $292K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$38K |
| Net Income | Q3 2026 · Mar 31, 2026 | $165K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$495K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$224K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$81K |
| Operating Income | Q3 2026 · Mar 31, 2026 | $62K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$343K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$213K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $2.55M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $7.64M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $1.98M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $6.52M |